Evaxion Biotech (EVAX)
3.12
+0.04 (1.30%)
Upcoming Events
Latest Headlines
Form 6-K Evaxion A/S For: Aug 20
August 20, 2026 7:35 AM - SEC Filing
Evaxion posts $3.7M Q2 loss, advances cancer vaccine pipeline
August 20, 2026 7:31 AM - StreetInsider
Form 6-K Evaxion A/S For: Jun 30
August 20, 2026 7:30 AM - SEC Filing
Evaxion announces business update and second quarter 2026 financial results
August 20, 2026 7:30 AM - StreetInsider
Form 6-K Evaxion A/S For: Aug 17
August 17, 2026 8:05 AM - SEC Filing
Evaxion adds brain cancer vaccine program, drops EVX-03
August 17, 2026 8:02 AM - StreetInsider
Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program
August 17, 2026 8:00 AM - Globe NewsWire
Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program
August 17, 2026 8:00 AM - StreetInsider
Form 6-K Evaxion A/S For: Aug 14
August 14, 2026 8:05 AM - SEC Filing
Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026
August 14, 2026 8:00 AM - StreetInsider
Form 6-K Evaxion A/S For: Jul 17
July 17, 2026 7:31 AM - SEC Filing
Evaxion to present 3-year cancer vaccine data at ESMO 2026
July 17, 2026 7:15 AM - StreetInsider
Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026
July 17, 2026 7:15 AM - StreetInsider
Form 6-K Evaxion A/S For: Jul 12
July 13, 2026 6:02 AM - SEC Filing
Evaxion shares preclinical data for CMV vaccine program EVX-V1
July 12, 2026 9:30 AM - StreetInsider
Evaxion shares preclinical data for CMV vaccine program EVX-V1
July 12, 2026 9:30 AM - StreetInsider
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
July 12, 2026 9:30 AM - Globe NewsWire
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
July 12, 2026 9:30 AM - StreetInsider
Form 6-K Evaxion A/S For: Jul 01
July 1, 2026 8:05 AM - SEC Filing
Evaxion to present CMV vaccine data at Montreal conference
July 1, 2026 8:00 AM - StreetInsider
Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop
July 1, 2026 8:00 AM - StreetInsider
eGenesis names new CFO and CCO as clinical programs advance
June 22, 2026 8:00 AM - StreetInsider
eGenesis Appoints Glenn S. Vraniak as Chief Financial Officer and Jennifer Bergheiser as Chief Commercial Officer
June 22, 2026 8:00 AM - BizWire
HowToRobot Announces Record Q1 Revenue, 94% Gross Margins, and Surge in Enterprise Automation Demand
June 17, 2026 7:30 AM - Globe NewsWire
Form 6-K Evaxion A/S For: Jun 12
June 12, 2026 6:03 AM - SEC Filing
Evaxion receives Prix Galien UK Award for Best digital health solution
June 12, 2026 3:00 AM - StreetInsider
Form 6-K Evaxion A/S For: Jun 11
June 11, 2026 6:04 AM - SEC Filing
Evaxion presents preclinical data for acute myeloid leukemia vaccine
June 11, 2026 2:00 AM - StreetInsider
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
June 11, 2026 2:00 AM - Globe NewsWire
Evaxion presents preclinical data for leukemia vaccine candidate
June 11, 2026 2:00 AM - StreetInsider
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
June 11, 2026 2:00 AM - StreetInsider
Full Article List